D-Serine 抑制非离子体NMDA受体的信号传递
bioRxiv : the preprint server for biology
|June 10, 2024
概括
d-氨酸的可用性调节NMDA受体 (NMDAR) 信号传递. 减少d-氨酸会增强非离子转移性NMDAR活性,而足够的d-氨酸会抑制它,解决了突触可塑性研究中的争议.
科学领域:
- 神经科学是一个神经科学.
- 分子和细胞生物学分子和细胞生物学
- 突触性可塑性 突触性可塑性
背景情况:
- NMDA型谷氨酸受体 (NMDARs) 对突触可塑性,学习和记忆至关重要.
- 对于通道开放和流入,NMDARs需要谷氨酸和协同激动剂,如d-serine,用于通道开放和流入.
- 关于NMDAR的离子流独立 (非离子otropic) 信号作用存在争议.
研究的目的:
- 为了调查可变的协同激素 (d-serine) 可用性是否会导致非离子转移性NMDAR信号研究中的相互矛盾结果.
- 阐明d-氨酸在调节NMDAR介导的突触可塑性的作用.
主要方法:
- 在小鼠的急性海马切片和培养神经元中进行的实验.
- 酶性清除内源性协同激素剂以操纵d-氨酸水平.
- 利用NMDAR孔隙阻断剂MK801和基于FRET的测试来测量受体构造变化.
主要成果:
- 通过非离子转移性NMDAR信号诱导的d-胺增强长期抑郁症 (LTD) 的酶清除.
- 和的d-氨酸度抑制了LTD和脊柱收缩,由非离子转移性NMDAR信号介导.
- 在GluN1细胞质域中,d-serine阻断了NMDA诱导的 conformational 运动,这表明它抑制了非离子体信号传递.
结论:
- d-氨酸的可用性是影响非离子转移性NMDAR信号传递和突触可塑性的关键因素.
- d-胺活性抑制离子流量独立的NMDAR信号,解决了之前的实验矛盾.
- 对于d-氨酸的发育调节表明它在关键发育时期调节可塑性的作用.
相关概念视频
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
1.8K
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
1.8K
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.2K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.2K
Depolarizing Blockers: Mechanism of Action
1.5K
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
1.5K
Drugs Affecting Neurotransmitter Release or Uptake
1.0K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.0K
Skeletal Muscle Relaxants: Adverse Effects
356
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
356
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
673
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
673


